Impact of COVID-19 on the Management of Early-Stage Breast Cancer - Episode 4

TAILORx Trial

A review of the TAILORx trial using the Oncotype DX assay to inform decisions in the adjuvant setting for treatment of HR+, HER2- breast cancer.